Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration
Year: 2006
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: New England Journal of Medicine
DOI: 10.1056/nejmoa062655
Authors: David M. Brown, Peter K. Kaiser, Mark Michels, Gisele Soubrane, Jeffrey S. Heier, Robert Y. Kim, Judy P. Sy, Susan Schneider
Language: English
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2085712747
